Paclitaxel/doxorubicin is superior to standard first-line therapy in metastatic breast cancer Sep. 28, 1999
French investigators continue research on homocamptothecins; dual Topo I and II inhibitor identified Sep. 27, 1999
Phase I results of Bay-12-9566 presented at ECCO 10; Bayer halts all trials on the compound Sep. 27, 1999
RSS